The impact of the commencement time of hydrogel wound covering/protective material (Episil) for oral mucositis caused by chemotherapy and radiotherapy on cancer patients and cancer treatments. - A prospective observational study -

The differences in effectiveness of hydrogel wound covering/protective material (Episil) for oral mucositis caused by chemotherapy and chemoradiotherapy due to the commencement time. - A prospective observational study - - An observational study on the appropriate time of Episil commencement for oral mucositis caused by chemotherapy and chemoradiotherapy.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041462

Enrollment

Registered

2020-08-19

Start date

2019-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck cancer, Hematological malignancy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Allogeneic hematopoietic stem cell transplant patients and head and neck chemo-radiotherapy patients. 2)Patients who are considered to be appropriate using hydrogel wound covering/protection material.

Exclusion criteria

Exclusion criteria: 1)Oral cancer patients. 2)Patients with wounds except for oral mucositis caused by chemotherapy or radiotherapy. 3)Patients with pain management using opioids before the commencement of hydrogel wound covering/protection material application. 4)Patients who are determined to be inappropriateb y the attending physician.

Design outcomes

Primary

Measure	Time frame
Oral pain	—

Secondary

Measure	Time frame
Oral mucositis Body weight Administration of opioid Blood test results	—

Countries

Japan

Contacts

Public ContactKouji Katsura

Niigata University Medical and Dental Hospital Department of Oral Radiology

katsu@dent.niigata-u.ac.jp025-223-6161

Outcome results